IFN-γ Antagonist includes a peptide-derived framework used to probe receptor interactions and competitive binding processes. Charged and polar residues modulate solubility and structural stability. Researchers employ it to examine steric requirements for recognition. Applications extend to ligand tuning, pathway mapping, and advanced peptide engineering.
CAT No: R2453
CAS No:158040-83-6
Synonyms/Alias:IFN-g Antagonist;158040-83-6;IFN-gamma Antagonist;IFN-|A Antagonist 1;MFCD30475311;HY-P4717;DA-64386;FI108757;CS-0656161;IFN-g Antagonist (H-L-Ala-L-Tyr-L-Cys(Acm)-L-Arg-L-Asp-Gly-L-Lys-L-Ile-Gly-L-Pro-L-Pro-L-Lys-L-Leu-L-Asp-L-Ile-L-Arg-L-Lys-L-Glu-L-Glu-L-Lys-L-Gln-L-Ile-OH);
IFN-g Antagonist is a specialized biochemical compound designed to inhibit the activity of interferon-gamma (IFN-γ), a critical cytokine involved in immune regulation, inflammation, and host defense mechanisms. As a targeted inhibitor, this molecule enables precise modulation of IFN-γ-mediated signaling pathways, making it a valuable tool for dissecting the roles of cytokines in immunological processes. Its utility extends across a range of experimental contexts where understanding or controlling IFN-γ activity is essential, supporting advanced research in immunology, cell biology, and molecular signaling.
Immunological pathway analysis: The antagonist is frequently employed in studies aiming to unravel the complexities of cytokine signaling networks. By selectively blocking IFN-γ activity, researchers can delineate downstream effects and cross-talk with other immune mediators, enabling a clearer understanding of cellular responses such as macrophage activation, antigen presentation, and T cell differentiation. This targeted inhibition is instrumental for mapping the functional consequences of IFN-γ engagement in both innate and adaptive immune responses.
Inflammation modeling: In vitro and ex vivo models of inflammation benefit significantly from the use of IFN-γ antagonists to assess the contribution of this cytokine to pro-inflammatory cascades. By incorporating the antagonist into experimental systems, scientists can simulate conditions of IFN-γ deficiency or neutralization, thereby elucidating its role in the regulation of cytokine release, chemokine expression, and leukocyte recruitment. Such studies are vital for identifying key drivers of inflammatory processes and for validating therapeutic targets in preclinical research.
Signal transduction research: The compound serves as a precise tool for dissecting JAK-STAT and other IFN-γ-dependent signaling pathways. Its application allows for the controlled inhibition of receptor-mediated events, facilitating the study of transcriptional regulation, phosphorylation dynamics, and gene expression profiles downstream of IFN-γ stimulation. This level of mechanistic insight is crucial for understanding how cellular responses are orchestrated and for identifying nodes of regulation within complex signaling networks.
Autoimmunity and tolerance investigations: The antagonist is utilized in experimental models to probe the involvement of IFN-γ in the development and maintenance of immune tolerance or the breakdown thereof in autoimmune conditions. By modulating IFN-γ activity, researchers can assess its effects on processes such as regulatory T cell function, autoantigen presentation, and the balance between pro- and anti-inflammatory cytokines. These investigations support the identification of molecular mechanisms underlying immune dysregulation.
Cellular assay development: The IFN-γ antagonist is a valuable reagent in the design and optimization of cell-based assays where modulation of cytokine activity is required. Its inclusion enables the creation of controlled experimental conditions to evaluate the specificity and efficacy of test compounds, antibodies, or genetic interventions targeting the IFN-γ axis. This application underpins the development of robust, reproducible assays for high-throughput screening and mechanistic studies in immunology and cell signaling research.
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More